Statins & ALS Risk Calculator
Assess Your Situation
Based on the latest medical evidence, this tool helps you understand your personal risk factors related to statin use and ALS.
When you're taking statins to lower your cholesterol, the last thing you want to hear is that they might be linked to ALS - a devastating neurodegenerative disease. The fear isn't unfounded. Since 2007, reports have surfaced suggesting statins could trigger or worsen ALS, also known as Lou Gehrig's disease. But here's the truth: statins are not causing ALS. The evidence doesn't support it. In fact, the more you dig into the science, the clearer it becomes that the real issue isn't statins causing ALS - it's confusion between symptoms.
Where Did the Fear Come From?
The alarm started with reports to the FDA. In 2007, doctors and patients began filing spontaneous reports linking statin use to ALS symptoms. These weren't controlled studies - just individual cases. The FDA took it seriously. They reviewed 41 major clinical trials involving thousands of people, all with at least six months of follow-up. The result? No increase in ALS cases among statin users compared to those on placebo. In October 2008, the FDA said clearly: "Healthcare professionals should not change prescribing practices. Patients should not stop taking statins." But the story didn't end there. In 2024, a genetic study using Mendelian Randomization claimed a strong link between three statins - atorvastatin, simvastatin, and rosuvastatin - and higher ALS risk. The numbers were startling: one statin showed an odds ratio of nearly 700,000. That sounds terrifying. But experts immediately raised red flags. Genetic studies like this can be misleading if they don't account for other biological factors (called pleiotropy). The odds ratio for rosuvastatin, for example, is so high it's biologically implausible. It’s like saying eating toast causes a meteor strike - mathematically possible, but not real.What the Biggest Population Studies Say
The most reliable evidence comes from large, real-world population studies. In March 2024, researchers in Norway published a landmark analysis of 524 ALS patients using national health registries that tracked everyone from 1972 to 2003. They compared those who took statins to those who didn’t. After adjusting for age, sex, smoking, cholesterol levels, and even use of riluzole (the only FDA-approved ALS drug), they found no difference in survival. The hazard ratio? 0.97 - meaning statin users lived just as long as non-users. The difference in survival time? Less than a month - not even statistically meaningful. Even more telling: 21% of ALS patients in the study stopped taking statins in the year before diagnosis. Why? Because early ALS symptoms - muscle weakness, cramps, fatigue - look a lot like common statin side effects. So people stopped the medication thinking it was causing the problem. But the data shows: those who stopped had worse outcomes. Not because statins were harming them - because they were already in the early, invisible phase of ALS.Long-Term Use Might Actually Help
Here’s the twist: while short-term statin use might seem linked to ALS (because people start taking them when symptoms begin), long-term use appears to reduce risk. A 2024 study in Neurology found that men who took statins for more than three years had a lower chance of developing ALS. Another study from Harvard in 2022 showed the same pattern. The longer you’re on statins, the lower your ALS risk - especially in men. Why? It might have nothing to do with cholesterol. Statins have powerful anti-inflammatory effects. In lab studies, lovastatin and atorvastatin reduced motor neuron loss in mice by up to 30%. They lowered inflammation in brain cells called microglia and astrocytes - the same cells that go haywire in ALS. One 2018 study showed simvastatin blocked key inflammatory signals linked to neurodegeneration. This isn't just theory. It’s biology.
What Major Medical Groups Say Today
The American Heart Association still lists statins as first-line treatment for high cholesterol. The European Medicines Agency reviewed the evidence in 2023 and concluded: "No causal association has been established." The Mayo Clinic updated its patient page in January 2024 with a blunt statement: "There's no good evidence that statins cause or trigger ALS." Even the FDA, which initially sounded the alarm, hasn’t changed its stance. They still say the benefits of statins far outweigh any unproven risk. The CDC’s National ALS Registry, which tracks potential causes of ALS, has funded 37 research projects - including five new ones in 2025 - to study lipid metabolism and neurodegeneration. But so far, no study has proven statins cause ALS.What You Should Do If You Have ALS
If you’ve been diagnosed with ALS and are taking statins, don’t stop. The evidence says you’re not making things worse - you might be helping yourself. Dr. Shafeeq Ladha, lead author of the Norwegian study, put it plainly: "Statin use should not routinely be discontinued upon diagnosis." Many patients stop statins out of fear. About 35% of ALS patients ask about it. About 12% actually quit. That’s dangerous. Statins protect against heart attacks and strokes - conditions that kill far more people than ALS. Dr. Merit Cudkowicz, Chief of Neurology at Massachusetts General Hospital, says: "Many patients stop statins unnecessarily after an ALS diagnosis, which may put them at risk for preventable cardiovascular events." The American Academy of Neurology’s 2023 guidelines say: "Statin therapy should be continued in ALS patients with established cardiovascular indications." Only stop if you’re having severe muscle pain or weakness that your doctor can’t explain as ALS progression. Even then, don’t quit on your own. Talk to your neurologist and cardiologist together.
Why This Confusion Keeps Happening
ALS is rare - only 1.5 to 2.5 new cases per 100,000 people each year. Statins are everywhere - nearly 39 million Americans take them. That means a few ALS patients will be on statins. Pure coincidence. When two common things happen together, people assume one caused the other. That’s called correlation bias. The early symptoms of ALS - muscle cramps, fatigue, tripping - are also common side effects of statins. So when someone starts feeling weak, they blame the statin. They stop taking it. Then, the disease keeps progressing. They think: "If I’d never taken that pill, I wouldn’t be like this." But the science says: the statin wasn’t the cause. The ALS was already there.The Bottom Line
Statins do not cause ALS. The idea that they do is based on coincidence, misinterpreted data, and fear. The strongest evidence - from population studies, clinical trials, and biological research - shows no causal link. In fact, long-term use may lower your risk. If you’re on statins for heart health, keep taking them. If you’ve been diagnosed with ALS, don’t stop unless your doctor says to. The real danger isn’t the medication. It’s the myth.Do statins cause ALS?
No, there is no convincing evidence that statins cause ALS. Major health agencies including the FDA, Mayo Clinic, and European Medicines Agency have reviewed the data and found no causal link. Early reports were based on coincidence - people with early ALS symptoms sometimes start statins because they visit doctors for muscle issues, which look like statin side effects.
Should I stop taking statins if I have ALS?
No, unless you're experiencing severe muscle symptoms your doctor can't explain as ALS progression. Stopping statins increases your risk of heart attack and stroke. Studies show ALS patients who continue statins have the same survival rates as those who stop. The Norwegian study found no harm - and potential benefit - from continuing statin therapy.
Can statins help slow ALS progression?
Some research suggests long-term statin use may reduce ALS risk, especially in men. Animal studies show statins like lovastatin and atorvastatin reduce inflammation in brain cells and protect motor neurons. While this doesn't mean statins cure ALS, they may have neuroprotective effects. More human trials are needed, but current evidence supports continuing statins for cardiovascular health in ALS patients.
Why do some studies say statins increase ALS risk?
Some studies, especially genetic ones like Mendelian Randomization, report high risk numbers - but these are flawed. They often ignore reverse causality: people may start statins because they already have early ALS symptoms. Short-term statin use shows a link, but long-term use shows protection. The strongest studies - large population-based ones - find no increased risk.
What should I do if I'm worried about statins and ALS?
Talk to your doctor - both your neurologist and cardiologist. Don't make decisions based on online stories or fear. Ask for the evidence. Review your personal risk: if you have high cholesterol, heart disease, or a family history of stroke, statins are likely saving your life. The risk of stopping them is far greater than the unproven risk of ALS.
